Skip to the page

Data / Product recalls / VRA Formulations LLC

VRA Formulations LLC: 1 recall in 2024 (FDA)

VRA Formulations LLC, Medley, FL, is named in 1 recall in 2024: all from the FDA. The latest, on April 3, 2024, covers TestoFREAK Maximize Testosterone Dietary Supplement 60 capsules per dark amber bottle, 100 bottles per case. Hazard: Due to sub-potent levels of Zinc. Source: FDA F-1125-2024.

SpecStream is the live web data engine for teams and agents. It reads every recall from the CPSC, FDA and NHTSA each morning, and this page is that reading. Ask for the brands, categories or stores you follow and each new recall arrives in your sheet, CRM, Slack or agent as the agency publishes it.

Country
United States
Location
Medley, FL
Agencies
U.S. Food and Drug Administration
First recall
April 3, 2024
Latest recall
April 3, 2024

Recalls

Each recall is listed once, with the role this firm has in it. Roles: recalling firm (1).

DateAgencyProductHazardUnitsRemedySold atRoleSource
April 3, 2024FDATestoFREAK Maximize Testosterone Dietary Supplement 60 capsules per dark amber bottle, 100 bottles per caseDue to sub-potent levels of Zinc1569 BottlesVoluntary recall, Class III, terminatedRecalling firmaccessdata.fda.gov

By agency

AgencyRecallsLatest
U.S. Food and Drug Administration1April 3, 2024

Categories

CategoryRecalls
Dietary supplements1

Where each agency publishes its recalls

Updated April 3, 2024. Read from U.S. Food and Drug Administration recall data. CC0 1.0 (openFDA). Recalls are as the agencies published them: the CPSC, FDA (food enforcement reports) and NHTSA. A firm is one firm only when its exact name and country match; the CPSC and FDA print no firm ID. Stores are listed only when the agency's sold-at text names them, and an agency often adds that more stores sold the product. Categories are grouped by SpecStream from the words in the agency's title and product text. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.